Gateway Pundit states that a young boy died from a heart stoppage after getting the company's test gene treatment for Duchenne muscular dystrophy.
“A Pfizer representative informed Reuters in a special email, “A fatal serious side effect was recorded as heart stoppage for a participant in the Phase 2 DAYLIGHT study.
“Pfizer’s gene therapy trial is currently testing children two to three-year-olds who have Duchenne muscular dystrophy.”
To read the full Gateway Pundit story, click HERE.
